These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37185283)

  • 1. ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.
    Gomes D; Sobolewski C; Conzelmann S; Schaer T; Lefai E; Alfaiate D; Tseligka ED; Goossens N; Tapparel C; Negro F; Foti M; Clément S
    Sci Rep; 2023 Apr; 13(1):6767. PubMed ID: 37185283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.
    Mohamed AA; Loutfy SA; Craik JD; Hashem AG; Siam I
    Virol J; 2011 Nov; 8():496. PubMed ID: 22044490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
    Tsochatzis E; Manolakopoulos S; Papatheodoridis GV; Hadziyannis E; Triantos C; Zisimopoulos K; Goulis I; Tzourmakliotis D; Akriviadis E; Manesis EK; Archimandritis AJ
    Aliment Pharmacol Ther; 2009 Nov; 30(9):947-54. PubMed ID: 19604179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
    Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes.
    Benegiamo G; Vinciguerra M; Mazzoccoli G; Piepoli A; Andriulli A; Pazienza V
    Dig Dis Sci; 2012 Jun; 57(6):1598-603. PubMed ID: 22526584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
    Patra T; Sasaki R; Meyer K; Ray RB; Ray R
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
    Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
    J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
    Jian Wu Y; Shu Chen L; Gui Qiang W
    Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of insulin resistance in chronic hepatitis C.
    Douglas MW; George J
    World J Gastroenterol; 2009 Sep; 15(35):4356-64. PubMed ID: 19764085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets.
    Clément S; Peyrou M; Sanchez-Pareja A; Bourgoin L; Ramadori P; Suter D; Vinciguerra M; Guilloux K; Pascarella S; Rubbia-Brandt L; Negro F; Foti M
    Hepatology; 2011 Jul; 54(1):38-49. PubMed ID: 21465511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
    García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
    J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.
    Chang ML; Kuo CJ; Pao LH; Hsu CM; Chiu CT
    Virulence; 2017 Oct; 8(7):1255-1264. PubMed ID: 28267407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
    Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
    Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.
    Parvaiz F; Manzoor S; Iqbal J; Sarkar-Dutta M; Imran M; Waris G
    World J Gastroenterol; 2015 Nov; 21(43):12361-9. PubMed ID: 26604643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
    Abid K; Pazienza V; de Gottardi A; Rubbia-Brandt L; Conne B; Pugnale P; Rossi C; Mangia A; Negro F
    J Hepatol; 2005 May; 42(5):744-51. PubMed ID: 15826725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.
    Gao TT; Qin ZL; Ren H; Zhao P; Qi ZT
    Virol J; 2015 Feb; 12():12. PubMed ID: 25645159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Association between Hepatitis C Virus core Gene Variation 70/91aa and Insulin Resistance.
    Scalioni LP; da Silva AP; Miguel JC; Espírito Santo MPD; Marques VA; Brandão-Mello CE; Villela-Nogueira CA; Lewis-Ximenez LL; Lampe E; Villar LM
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.